Toru FUJINAGA
- Biomaterials top 0.5%
- Surgery top 5%
- Small Animals top 0.5%
- Biomedical Engineering top 5%
- Molecular Biology
- Co-authors
- Masahiro OkumuraHiroshi UenoTakashi MoriTsuyoshi KADOSAWASatoshi TakagiGonhyung KimDarko BosnakovskiMorimichi Mizuno
- Topics
- Veterinary Equine Medical Research (20 papers)Virus-based gene therapy research (15 papers)Osteoarthritis Treatment and Mechanisms (14 papers)
- Cited by
- EquineBiomaterialsRehabilitation
- Partner nations
- JapanSouth KoreaKenya
In The Last Decade
Toru FUJINAGA
122 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Biomaterials 1.2k
- Surgery 798
- Small Animals 580
- Biomedical Engineering 562
- Molecular Biology 557
Countries citing papers authored by Toru FUJINAGA
This map shows the geographic impact of Toru FUJINAGA's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toru FUJINAGA with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toru FUJINAGA more than expected).
Fields of papers citing papers by Toru FUJINAGA
This network shows the impact of papers produced by Toru FUJINAGA. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toru FUJINAGA. The network helps show where Toru FUJINAGA may publish in the future.
Co-authorship network of co-authors of Toru FUJINAGA
This figure shows the co-authorship network connecting the top 25 collaborators of Toru FUJINAGA. A scholar is included among the top collaborators of Toru FUJINAGA based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toru FUJINAGA. Toru FUJINAGA is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 395 | |
| 2 | 13 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 26 | |
| 7 | 11 | |
| 8 | 62 | |
| 9 | Topical formulations and wound healing applications of chitosanbreakdown → | 630 |
| 10 | 21 | |
| 11 | 17 | |
| 12 | 2 | |
| 13 | 2 | |
| 14 | 3 | |
| 15 | 60 | |
| 16 | 23 | |
| 17 | 24 | |
| 18 | 2 | |
| 19 | 51 | |
| 20 | Clinico-hematologic and serological comparison of Japanese and Russian strains of Theileria sergenti. | 62 |
About Toru FUJINAGA
Toru FUJINAGA is a scholar working on Equine, Small Animals and Parasitology, having authored 126 papers that have together received 4.3k indexed citations. Recurring topics across this work include Veterinary Equine Medical Research (20 papers), Virus-based gene therapy research (15 papers) and Osteoarthritis Treatment and Mechanisms (14 papers). The work is most often cited by research in Equine (409 citations), Biomaterials (1.2k citations) and Rehabilitation (545 citations). Toru FUJINAGA has collaborated with scholars based in Japan, South Korea and Kenya. Frequent co-authors include Masahiro Okumura, Hiroshi Ueno, Takashi Mori, Tsuyoshi KADOSAWA, Satoshi Takagi, Gonhyung Kim, Darko Bosnakovski, Morimichi Mizuno, Mitsuyoshi Hagio and Yoshiharu Okamoto. Their work appears in journals such as Journal of Biological Chemistry, Biomaterials and Advanced Drug Delivery Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.